Xavier Roblin
19PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (19)
Sort by Publication Date:
|Oct 13, 2025
Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis.Marc Ferrante, Laurent Peyrin-Biroulet, Perttu Arkkila
|Sep 29, 2025
Gut Microbiota Are More Strongly Associated With Impairments in Health-Related Quality of Life Than Disease Activity in Inflammatory Bowel Disease.Robert D Little, Thisun C Jayawardana, Fan Zhang
|Jul 01, 2024
Mimics of inflammatory bowel disease: commonly encountered differentials of an uncommon condition.Kathryn Demase, Mark G Ward
|Feb 13, 2023
Use of imaging modalities for decision-making in inflammatory bowel disease.Stéphane Nancey, Mathurin Fumery, Mathias Faure
|Oct 27, 2022
Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease-Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous Biologics.Robert D Little, Mark G Ward, Emily Wright
|Sep 20, 2021
SARS-CoV-2 vaccination in patients with inflammatory bowel disease.Ralley E Prentice, Clarissa Rentsch, Aysha H Al-Ani
Pageof 4
Frequent Collaborators
5 joint publications
Sparrow Mp
2 joint publications
Robert D Little
2 joint publications
R W Leong
2 joint publications
David J Gibson
2 joint publications
Simon Ghaly
2 joint publications
Susan J Connor
2 joint publications
Britt Christensen
2 joint publications
Peter R Gibson
1 joint publications
N Mitrev
1 joint publications
W Chan
